Lab Director

Kim Gleason, PhD joined the Neway team as Director of Reproductive Laboratories. As an expert in IVF, Andrology, and Embryology for over 20 years, Dr Gleason served as Laboratory Director and Senior Embryologist for such prestigious programs as The Department of Obstetrics and Gynecology’s Division of Reproductive Endocrinology, Fertility, and IVF at George Washington University Hospital, and Valley Hospital Fertility Center in Paramus, New Jersey. She also served as the Director of Reproductive and Research Laboratories at Crozer-Chester Medical Center in Philadelphia.

Dr. Gleason earned her Bachelor of Science degree in Microbiology and Master of Science degree in Physiology/Pathobiology from Auburn University in Auburn, Alabama.  She received a Doctorate in Reproductive Physiology from the University of Arkansas in Fayetteville. During her doctoral studies, she was awarded a Nichols Science Research Grant for her work in the development of animal models to study early detection of infectious diseases transmitted by embryos.

Dr Gleason was named as One of 33 People to watch by South Jersey Magazine. She has written a multitude of articles describing technologies in the field of assisted reproductive medicine that have appeared in newspapers and magazines in the greater Philadelphia and New Jersey areas. Results of her research have been published in the scientific journal Fertility and Sterility, and have been presented at the national meetings of the American Society of Reproductive Medicine. Dr Gleason continues to publish research on improving IVF embryo culture conditions for purposes of increasing patient pregnancy outcomes through transfer of fewer embryos. She is an active member of the Delaware Valley Reproductive Biologists Group, and the American Society of Reproductive Medicine.

Bibliography & Presentations

Trophectoderm blastocyst (TE) biopsy results in higher pregnancy rate, lower multiple rate, and fewer cycles to pregnancy in gestational carriers. A. Nasseri, K. Gleason, C. Zollinger, M. Post, D. Chen, J. Grifo. 2015,Oct, 21 P-499.

Identification of Novel Cumulus Cell Molecular Markers Predictive of Oocyte Competence: Confirmation With Pregnancy Outcome. V.S Nandula, A. Naini, M. Mansukhani, K. Gleason, A. Nasseri. ASRM O-345 2001, Oct, 19. O-345.

What Defines Egg Quality? K. Gleason. Conceptions Magazine, Spring 2003.

The Male Factor: Current Approaches to Understanding and Treating Male Infertility.  G. Taliadouros, K. Gleason. Conceptions Magazine, Spring 2002.

A New Way To Preserve Embryos. K. Gleason. Conceptions Magazine, Spring 2002

Sperm Morphology as a Predictor of Outcome with Intrauterine Inseminations After Ovarian Stimulation With Clomiphene Citrate/Tamoxifen or Gonadotropins. K. Gleason, H.M. Ray, S.M. Carney, C.H, Wu, G.S. Taliadouros. Fertility and Sterility Supplement, 2002.

An Exciting IVF Advance: The Basics of Blastocyst Culture and Transfer. K. Gleason. Conceptions Magazine, Fall 2000

Are Cytokines and Growth Factors Resonsible for the Detrimental Effects of Hydrosalpigeal Fluid on Pregnancy Rates After In Vitro Fertilization-Embryo Transfer? L. Barmat, K. Nasti, Xu Yang, S. Spandorpher, A. Kowalki, A. El-Roeiy. Fert Steril 72(6):1110-1112. 1999.

Are Cytokines/Growth Factors Resonsible for the Detrimental Effects of Hydrosalpigeal Fluid (HF) on IVF-ET Pregnancy Rates?  L. Barmat, K. Nasti, Xu Yang, S. Spandorpher, A. Kowalki, A. El-Roeiy. Fertility and Sterility Supplement, 1998

In Vitro Development of Bovine Embryos As Affected by Different Lots of Bovine Serum Albumin and Citrate. R.W. Rorie, G.F. Miller, K.B. Nasti.  Theriogenology 42(3):97-103. 1994.